1 Y ·ترجمه کردن

SEVERAL PHARMACEUTICAL COMPANIES HAVE DEMONSTRATED A PREFERENCE TO OUTSOURCE THEIR PATIENT RECRUITMENT OPERATIONS

Clinical trials form an essential part of the overall drug development process, evaluating the safety and efficacy of a drug candidate. Studies suggest that around 40% of the total investment made for the development of a drug candidate is dedicated to clinical trials.

However, the conduct of such trials is often fraught with challenges, including scientific and operational complexity, concerns associated with recruitment and retention of suitable patients, issues related to data handling and increasingly stringent regulatory guidelines. Further, owing to the inherent complexity of the overall process and involvement of several different stakeholders, these trials are prone to delays. It is worth mentioning that around 80% of the clinical trials are delayed due to insufficient patient recruitment.


For additional details, please visit link https://www.rootsanalysis.com/....reports/view_documen